Loading chat...
DE HB95
Bill
Status
6/15/2021
Primary Sponsor
Kimberly Williams
Click for details
AI Summary
-
Requires individual, group, and blanket health insurance policies to provide coverage for medically necessary epinephrine autoinjectors for individuals 18 years of age or under
-
Mandates that insurers include at least one formulation of epinephrine autoinjectors on the lowest tier of their drug formulary, minimizing out-of-pocket costs for patients
-
Applies to State employee health plans under Title 29 and public assistance/Medicaid programs under Title 31
-
Excludes accident-only, specified disease, hospital indemnity, Medicare supplement, long-term care, and disability income policies from the requirement
-
Allows standard policy provisions such as deductibles, coinsurance, and coordination of benefits to still apply to epinephrine autoinjector coverage
Legislative Description
An Act To Amend Title 18, Title 29, And Title 31 Of The Delaware Code Relating To Insurance Coverage Of Epinephrine Autoinjectors.
Last Action
Signed by Governor
6/15/2021